Please login or register first to view this content.
Kidney Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Potential Med Errors Prompt FDA Action on Vinca Alkaloid Labeling
Lower Risk of CKD Stage Progression Found With Apixaban
Sparsentan Granted Orphan Drug Status for IgA Nephropathy
Finerenone Gets Priority Review for Diabetic Kidney Disease
Empagliflozin Under Review for Heart Failure with Reduced Ejection Fraction
Dapagliflozin Under Review for Chronic Kidney Disease
FDA Requests Clarification of Data to Complete Roxadustat Review
IV Iron Products: Adverse Events, Associated Costs Compared
FDA Approves Oxlumo for Primary Hyperoxaluria Type 1
New Dosing Option Approved for Imfinzi in NSCLC, Bladder Cancer
Pegcetacoplan Gets Priority Review for Paroxysmal Nocturnal Hemoglobinuria
Manufacturing Deficiencies Delay Decision on Sutimlimab for Cold Agglutinin Disease
Finerenone NDA Submitted for Diabetic Kidney Disease
Novel Medication Relieves Pruritus in Hemodialysis Cases
Apabetalone Prevents CV Events in High-Risk Diabetic CKD
Nivolumab Plus Cabozantinib Under Review for Renal Cell Carcinoma
Glecaprevir and Pibrentasvir Aid HCV D+/R- Kidney Transplants
FDA Approves New Formulation of Ultomiris for PNH and aHUS
